VI
Veru Inc
🇺🇸XNAS.VERUUnited StatesHealthcare
$2.35USDup +0.01 (+0.43%)ClosedEnd of day8:58 PM
Price$2.35+0.01 (+0.43%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US92536C2026
- CUSIP
- 976817106
Company
- Employees
- 20
- Headquarters
- Miami, United States
- Website
- https://verupharma.com
- CEO
- Dr. Mitchell S. Steiner F.A.C.S., M.D.
Market
- Shares outstanding
- 17.1M
- Market cap
- $40.07M
Highlights
- Market cap
- $40.07M
- EPS LTM
- -$0.80calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -2.94calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $303.45K-95.44%down year on year
- Net income
- -$13.61M+58.4%up year on year
- Gross margin
- 72%+86.95%up year on year
- Free cash flow
- -$26.04M+10.14%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.